한국코로나19진단키트 미국연방정부 납품계약현황 한국진단키트업체계약종합 20200413_안치용.pdf0.64MB 한국의 코로나19 진단기술이 세계적으로 우수성을 인정받고 있는 가운데 한국3개업체가 미국 연방정부와 계약을 마친 것으로 확인됐습니다 연방정부 조달데이터시스템 확인결과, 미국국토안보부산하 재난관리청[FEMA]는 지난 5일과 6일 SD바이오센서, YTS글로벌[솔젠트제품 미국판매사], 오상헬스케어등 3개업체와 코로나19진단키트 1142만4천달러 구매계약을 체결했습니다. 재난관리청이 가장 먼저 구매계약을 체결한 업체는 SD바이오센서로, 지난 5일 코로나19 진단키트를 518만4천달러에 구매키로 했으며, 6일에는 YTS글로벌로 부터 솔젠트 코로나19진단키트 324만달러어치, 또 같은 날 오상헬스케어와 코로나19진단키트 3백만달러어치를 구입합니다. 미..

트럼프,오늘미국산신속진단키트로재검진-음성판정

미국,올해1,2월마스크-인공호흡기등6천만달러어치중국수출드러나 마스크 1750만달러 수술복등 1360만달러 인공호흡기 2720만달러

트럼프,전국민에저녁8시'godblessamerica'합창호소

트럼프,마침내'전국민마스크착용'권고= 파우치박사,2월17일'마스크쓸이유1도없다'권고가뉴욕대재앙초래한셈

미국,'코로나19집단발병'항공모함루즈벨트함장전격해임

Dr.StephenSmithoneffectivenessofhydroxychloroquine:'Ithinkthisisthebeginningoftheendofthepandemic' 출처https://www.foxnews.com/media/dr-stephen-smith-on-effectiveness-of-hydroxychloroquine-with-coronavirus-symptoms-beginning-of-the-end-of-the-pandemic Dr. Stephen Smith on effectiveness of hydroxychloroquine: 'I think this is the beginning of the end of the pandemic' Dr. Stephen Smith, founder of TheSmith Center for Infectious Diseases and Urban Health, said on “The Ingraham Angle” on Wednesday night that he is optimistic about the use of antimalarial medicationsand antibioticsto treat COVID-19 patients calling it a www.foxnews.com Dr. Stephen Smith, Dr. Stephen Smith, founder of TheSmith Center for Infectious Diseases and Urban Health, said on “The Ingraham Angle” on Wednesday night that he is optimistic about the use of antimalarial medicationsand antibioticsto treatCOVID-19patients, calling it “a game-changer.” “I think this is the b..

30개국의사6200여명설문조사코로나19처방1위는진통제,2위는아지스로마이신,3위는하이드록시클로로퀸 출처 https://www.washingtontimes.com/news/2020/apr/2/hydroxychloroquine-rated-most-effective-therapy-do/ https://public-cdn.sermo.com/covid19/c8/be4e/4edbd4/dbd4ba4ac5a3b3d9a479f99cc5/wave-i-sermo-covid-19-global-analysis-final.pdf Hydroxychloroquine rated ‘most effective therapy’ by doctors for coronavirus: Global survey An international poll of more than 6,000 doctors released Thursday found that the antimalarial drug hydroxychloroquine was the most highly rated treatment for the novel coronavirus. www.washingtontimes.com Treatments & Efficacy: • 3 most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine. • Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in US, 17% in G..